A propos du fournisseur
Certifications
-
ISO 13485
Description du produit
Bioabsorbable Evolvemer™ TCP30PLGA is a biocompatible composite of bioabsorbable 85L/15G PLGA base polymer and beta-tri-calcium phosphate (β-TCP).
The β-TCP particle size distribution is optimized in this high-quality composite. This makes its processing easier and improves the mechanical properties of the final products.
Biocompatibility of the Evolvemer™ Composite has been evaluated according to ISO 10993-1:2009 (“Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process”). Based on the evaluation, Evolvemer™ Composite presents no risk of systemic toxicological effects.
Cytotoxicity and Plastic Class V tests have been conducted for Evolvemer™ Composite to support the biocompatibility statement of the composite. However, it is the sole responsibility of the manufacturer of the final end-use product to determine the biocompatibility of the final product.
Spécifications
| Marque | arctic biomaterials, evolvemer™ |
| Applications | orthopedics, sports medicine, veterinary, dental |
| Matériau | plga + β-tcp |
| Désignation chimique | - non spécifié - |
| Densité | - non spécifié - |
| Porosité | - non spécifié - |
| Usinabilité | - non spécifié - |
| Biodégradabilité | - non spécifié - |
| Résorbabilité | - non spécifié - |
| Renforcement (Composite) | - non spécifié - |
Produits similaires
Arctic Biomaterials (ABM) specializes in ultra-high strength, bioresorbable materials featuring its...
Evolvecomp™ next-generation bioabsorbable composites are engineered with ABM’s X3 bioactive natural...